These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6612815)

  • 1. [Presumed side effects of indomethacin in 2 premature infants].
    Pedersen S; Frost L
    Ugeskr Laeger; 1983 Jun; 145(25):1950-1. PubMed ID: 6612815
    [No Abstract]   [Full Text] [Related]  

  • 2. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug therapy of patent ductus arteriosus in premature and newborn infants].
    Bartel J
    Kinderarztl Prax; 1978 Dec; 46(12):644-8. PubMed ID: 366238
    [No Abstract]   [Full Text] [Related]  

  • 4. [Salt and water retention after the administration of indomethacin to premature infants].
    Chantepie A; Gold F; Laugier J
    Nouv Presse Med; 1980 Feb; 9(7):454-5. PubMed ID: 7360650
    [No Abstract]   [Full Text] [Related]  

  • 5. Indomethacin therapy in premature infants with patent ductus arteriosus.
    Rasidi C; Madiyono B; Usman IN
    Paediatr Indones; 1982; 22(3-4):70-6. PubMed ID: 7122105
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus].
    Seyberth HW; Müller H; Wille L; Plückthun H; Ulmer HE; Wolf D
    Monatsschr Kinderheilkd; 1983 Feb; 131(2):71-6. PubMed ID: 6843560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants].
    Lozano González CH; Holden AM; Hurtado del Río D; Segura MA
    Bol Med Hosp Infant Mex; 1982 Aug; 39(8):570-5. PubMed ID: 7182006
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indomethacin treatment of persistent ductus arteriosus in premature infants].
    Petersen S; Christensen NC; Lauridsen P; Pedersen SA; Ryssing E
    Ugeskr Laeger; 1983 Nov; 145(46):3564-7. PubMed ID: 6649140
    [No Abstract]   [Full Text] [Related]  

  • 11. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacologic treatment of patent ductus arteriosus in premature infants].
    Vázquez C; Cabrera A; Pastor E; Valls y Soler A
    An Esp Pediatr; 1983 Jun; 18(6):482-8. PubMed ID: 6625369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin and recurrent ileal perforations in a preterm infant.
    Giacoia GP; Azubuike K; Taylor JR
    J Perinatol; 1993; 13(4):297-9. PubMed ID: 8410386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome.
    Van Overmeire B; Van de Broek H; Van Laer P; Weyler J; Vanhaesebrouck P
    J Pediatr; 2001 Feb; 138(2):205-11. PubMed ID: 11174617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
    Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
    Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Closure of persistent ductus arteriosus in premature infants by drug therapy].
    Hencz P; Kertész E; Beviz J; Szeleczki T; Szekeres Z
    Orv Hetil; 1981 Oct; 122(41):2535-40. PubMed ID: 7033879
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose indomethacin for patent ductus arteriosus closure: how strong is the evidence?
    Manzar S
    Pediatrics; 2006 May; 117(5):1863; author reply 1863-4. PubMed ID: 16651359
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastrointestinal perforation following indomethacin therapy in very low birth weight infants.
    Nagaraj HS; Sandhu AS; Cook LN; Buchino JJ; Groff DB
    J Pediatr Surg; 1981 Dec; 16(6):1003-7. PubMed ID: 7338750
    [No Abstract]   [Full Text] [Related]  

  • 20. Localized intestinal perforation following intravenous indomethacin in premature infants.
    Wolf WM; Snover DC; Leonard AS
    J Pediatr Surg; 1989 Apr; 24(4):409-10. PubMed ID: 2732888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.